New research, contrary to previous studies, shows augmenting antidepressant therapy with an omega-3 fatty acid supplement does not result in improvement in levels of depression in patients with coronary heart disease (CHD).
The legal firm behind two actions that challenge the US qualified health claims system has asked a District of Columbia District Court to issue a summary judgment against the FDA over its selenium claims.
Adherence to a Mediterranean diet along with avoidance of Western-type foods may contribute to a reduction in postmenopausal breast cancer risk, claims new French study.
Daily consumption of a Chinese green tea extract may slow the damage of cigarette smoke in the lungs, according to results from a rat study from Hong Kong.
Increased intakes of vitamins C and E and other antioxidants from the diet may protect against DNA damage in people exposed to ionizing radiation such as pilots, says a new study.
Veteran food lawyer Jonathan W Emord has become the first non-scientist to be accepted onto the American College of Nutrition’s Certification Board for Nutrition Specialists (CBNS).
The Center for Science in the Public Interest says it has filed a lawsuit against Bayer over claims on One A Day supplements that selenium could prevent prostate cancer, on the grounds that existing products bearing the claim were not recalled.
Get your pitchforks ready! There are evil-doers out there! We’ve been conned: Probiotics don’t work. Dannon’s settling out of court, EFSA’s rejecting health claims, and the media is starting a witch hunt.
The US FDA is being sued over its health claims regime – actions that are unlikely to succeed according to most pundits – but they raise serious questions about healthy food messaging and free speech that are being felt globally.
Current recommendations for vitamin K are not being met, placing people at increased risk of age-related diseases such as cancer and heart disease, says a new analysis.
As with many relatively new ingredients, resveratrol has had to prove its safety and efficacy to gain regulatory approval in various markets since its widespread commercial availability in the early 1990s.
In the third part of a special series on resveratrol, NutraIngredients looks at the science behind the ingredient. Is the French Paradox exclusively due to resveratrol?
Increased intakes of the compound quercetin, found in onions and apples, may reduce the risk of developing cancer of the colon by 50 per cent, says a new study.
In the second part of a special series on resveratrol, NutraIngredients looks at the ingredient’s supply. What is it extracted from, how much resveratrol does it contain, and who is offering the ingredient?
Seven cups of green tea a day over the long-term may massively reduce the risk of death from colorectal cancer and heart disease, suggests a new study from Japan.
In the first part of a special series on resveratrol, NutraIngredients looks at the state of the market for the heart-health ingredient. What has driven growth so far, and what are the opportunities and challenges ahead?
A compound found in vegetables like broccoli, cabbage and cauliflower, may protect arteries from disease by boosting a natural defence mechanism, says a new study from the UK.
The products of prebiotic fermentation in the gut may prevent the growth, and promote the death of cancer cells in the colon, says a new study from Germany.
Increased intakes of antioxidant-rich fruit and vegetables may reduce the risk of developing non-Hodgkin lymphoma, says a new study from the Mayo Clinic
The FDA is being sued for the third time in three weeks, this time over its “censorship” of 13 antioxidant qualified health claims, which the attorney mounting the case says amounts to “contempt of federal court orders” dating from 1999.
Increasing the intake of omega-3 fatty acids, and decreasing intakes of omega-6, could reduce the risk of colorectal cancer, suggests a new study from China.
Biofortification of broccoli and tomatoes may lead to increased levels of potentially anti-cancer compounds, according to results of an American study.
Herbal extract supplier Sabinsa has received GRAS status for its curcumin antioxidant ingredient, opening up its use in certain food and beverage applications in the US, including baked goods, snacks and dairy products.
A court action has been lodged today which challenges the Food and Drug Administration (FDA) qualified health claims system via five disputed selenium health claims.
Lung cancer patients who were regular dietary supplement users prior to diagnosis may have better survival chances than non-users, says a new study from Norway.
Drinking five or more cups of green tea per day may reduce the risk of blood- and lymph-based cancers by about 50 per cent, says a new study from Japan.
SourceOne Global Partners is introducing high-potency citrus limonoids to the US market, developed using new technology that has made their production commercially viable, says the firm.
Phytosterols, commonly consumed to reduce cholesterol levels, may also “potentially prevent cancer development”, according to a new review of all the science.
Bayer Healthcare says it will change the health claims used on its One A Day vitamins following threats of a lawsuit claiming its prostate cancer health claims were misleading.
In an update to its position statement on Vitamin D, the American Academy of Dermatology has cautioned that some individuals may be at risk of “insufficiency”, and may therefore need to consume higher doses of the vitamin.
Ocean Spray has received a patent for methods of use of cranberry seed oil in applications designed to “treat” or “prevent” cancer and a host of other disease.
Vegetarians will develop less blood, bladder and stomach cancer than meat eaters, according to new research published in the British Journal of Cancer.
In the next episode of the recent selenium saga, a formal complaint was yesterday filed with the US Food and Drug Administration (FDA) requesting that the agency seize stocks of Bayer vitamins for making misleading prostate cancer health claims.
The US Food and Drug Administration (FDA) has said it could allow the use of certain – very qualified – health claims linking selenium intake to a reduced risk of bladder, prostate and thyroid cancer.
The US government is backing what is said to be the largest randomized trial of vitamin D and marine omega-3, to examine their impact on the reduction of heart disease and cancer.
Consuming green tea may reduce levels of compounds linked to prostate cancer progression, according to findings of a small study with 26 men with prostate cancer.
Bayer Healthcare could face a lawsuit in the United States for advertising that its One A Day vitamins could reduce prostate cancer due to their selenium content.
A comprehensive review of studies on the benefits of omega-3 consumption has led scientists to recommend the establishment of a Dietary Reference Intake (DRI) for EPA and DHA to reduce the risk of heart disease.
Increased intakes of vitamins C and E and beta-carotene may reduce the risk of cancer of the uterus, according to a new review and meta-analysis of the science to date.
Vitamin E tocotrienols are slowing coming out of the shadow of tocopherols. Stephen Daniells talks to Dr Barrie Tan from American River Nutrition, about new sources of tocotrienols, new entrants to the market, and where the health benefits lie.
Higher blood levels of selenium may reduce the incidence of skin cancer by about 60 per cent, according to a new study from Dutch and Australian researchers.
Increased intake of the flavonoid apigenin, found in celery, parsley, and tomato sauce, may reduce the risk of ovarian cancer by 20 per cent, suggests a new study from Harvard.
